Silicon Valley Capital Partners Grows Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Silicon Valley Capital Partners raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 16.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,547 shares of the healthcare conglomerate’s stock after purchasing an additional 2,085 shares during the period. Silicon Valley Capital Partners’ holdings in UnitedHealth Group were worth $7,359,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. State Street Corp lifted its holdings in UnitedHealth Group by 1.3% in the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock valued at $26,626,387,000 after purchasing an additional 563,554 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of UnitedHealth Group by 1.6% during the 3rd quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate’s stock worth $11,440,133,000 after acquiring an additional 318,039 shares during the period. Franklin Resources Inc. increased its position in UnitedHealth Group by 2.5% during the 3rd quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock worth $4,884,019,000 after purchasing an additional 193,800 shares in the last quarter. International Assets Investment Management LLC increased its position in UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares in the last quarter. Finally, Fisher Asset Management LLC increased its position in UnitedHealth Group by 3.5% during the 3rd quarter. Fisher Asset Management LLC now owns 3,197,167 shares of the healthcare conglomerate’s stock worth $1,869,320,000 after purchasing an additional 107,097 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts recently issued reports on UNH shares. Stephens increased their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Barclays lowered their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Finally, Truist Financial lowered their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Stock Performance

Shares of UNH opened at $526.68 on Monday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a market capitalization of $484.69 billion, a PE ratio of 33.98, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The business’s fifty day moving average price is $529.18 and its 200 day moving average price is $564.37.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period last year, the business posted $5.83 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.